Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7073280 | 1.00 | SMN1; SMN2 (0.39) | — | |
| Hydrochloric Acid SCHEMBL74754 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1337777 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL159221 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL5276199 | 1.00 | SMN1; SMN2 (0.39) | — | |
| SCHEMBL186262 | 0.97 | — | — | |
| SCHEMBL159223 | 0.97 | — | — | |
| SCHEMBL47274 | 0.97 | — | — | |
| SCHEMBL2236696 | 0.95 | — | — | |
| Methylene Chloride SCHEMBL29028670 | 0.93 | KIF11 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2019 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122030612-A | Shear-resistant slow-release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-119462826-B | Pseudo peptide compound and preparation method and application thereof | 成都普康唯新生物科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119462826-A | Pseudo peptide compound and preparation method and application thereof | 成都普康唯新生物科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119409588-A | Caffeoyl amino acid methyl ester derivative and preparation method and application thereof | 西北大学 | 2025-02-11 | — | — | CN | claimed |
| CN-119044360-A | Method for detecting impurities in glycine methyl ester hydrochloride by high performance liquid chromatography | 上药康丽（常州）药业有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-118743985-B | Solid waste-based modularized constructed wetland filler | 皖创环保股份有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118743985-A | Novel solid waste-based modularized constructed wetland filler | 皖创环保股份有限公司 | 2024-10-08 | — | — | CN | claimed |
| CN-118290360-A | Synthetic method of organic light response probe HBT-CN based on ESIPT effect, obtained probe and application thereof | 临沂大学 | 2024-07-05 | — | — | CN | claimed |
| CN-117903078-A | Amide derivative containing 3, 4-dichloro isothiazole, preparation method and application thereof | 南开大学 | 2024-04-19 | — | — | CN | claimed |
| WO-2005049567-A1 | A NOVEL SYNTHESIS OF 2-AZABICYCLIC-3-CARBOXYLIC ACIDS, USEFUL AS IMPORTANT DRUG INTERMEDIATES | BABU POTLURI RAMESH (IN) | 2005-06-02 | — | — | WO | claimed |
| CN-1608073-A | A method for preparing N-acyl lysophosphatidylcholine compound and a pharmaceutical composition containing the compound for treating metabolic bone disease | JHON GIL JA (KR) | 2005-04-20 | — | — | CN | claimed |
| US-20050014722-A1 | Process for preparing n-acylated lysophosphatidylcholine and pharmaceutical composition for treatment of metabolic bone disease comprising said compounds | JHON, GIL-JA (KR) | 2005-01-20 | — | — | US | claimed |
| WO-2004067575-A1 | WATER SOLUBLE AND BIOCOMPATIBLE GELS OF HYALURONIC ACID CROSS-LINKED WITH BI-FUNCTIONAL L-AMINOACIDS OR L-AMINOESTERS | BIOSPHERE S.P.A. (IT) | 2004-08-12 | — | — | WO | claimed |
| WO-2003053984-A1 | A PROCESS FOR PREPARING N-ACYLATED LYSOPHOSPHATIDYLCHOLINE AND A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF METABOLIC BONE DISEASE COMPRISING SAID COMPOUNDS | JHON GIL-JA (KR) | 2003-07-03 | — | — | WO | claimed |
| US-20030096879-A1 | Gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters or mixtures thereof | BIOSPHERE S.P.A. (IT) | 2003-05-22 | — | — | US | claimed |
| EP-1261646-A1 | GELS OF HYALURONIC ACID CROSS-LINKED WITH BI-FUNCTIONAL L-AMINOACIDS OR L-AMINOESTERS OR MIXTURES THEREOF | S.F.I.R. Societa' Fondiaria Industriale Romagnola; S.P.A. (IT) | 2002-12-04 | — | — | EP | claimed |
| WO-2001058961-A1 | GELS OF HYALURONIC ACID CROSS-LINKED WITH BI-FUNCTIONAL L-AMINOACIDS OR L-AMINOESTERS OR MIXTURES THEREOF | S.F.I.R. S.P.A. SOCIETA' FONDIARIA INDUSTRIALE ROMAGNOLA (IT) | 2001-08-16 | — | — | WO | claimed |
| CN-1040212-C | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them | YEDA RES & DEV (IL) | 1998-10-14 | — | — | CN | claimed |
| US-5650292-A | PHOTOSENSITIZERS IN PHOTODYNAMIC THERAPY AND IN DIAGNOSIS OF TUMORS | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 1997-07-22 | — | — | US | claimed |